학술논문
A national population-based study of cannabis use and correlates among U.S. veterans prescribed opioids in primary care
Document Type
article
Author
Source
BMC Psychiatry, Vol 23, Iss 1, Pp 1-10 (2023)
Subject
Language
English
ISSN
1471-244X
Abstract
Abstract Background Cannabis is marketed as a treatment for pain. There is limited data on the prevalence of cannabis use and its correlates among Veterans prescribed opioids. Objective To examine the prevalence and correlates of cannabis use among Veterans prescribed opioids. Design Cross-sectional study. Participants Veterans with a urine drug test (UDT) from Primary Care 2014–2018, in 50 states, Washington, D.C., and Puerto Rico. A total of 1,182,779 patients were identified with an opioid prescription within 90 days prior to UDT. Main measures Annual prevalence of cannabis positive UDT by state. We used multivariable logistic regression to assess associations of demographic factors, mental health conditions, substance use disorders, and pain diagnoses with cannabis positive UDT. Results Annual prevalence of cannabis positive UDT ranged from 8.5% to 9.7% during the study period, and in 2018 was 18.15% in Washington, D.C. and 10 states with legalized medical and recreational cannabis, 6.1% in Puerto Rico and 25 states with legalized medical cannabis, and 4.5% in non-legal states. Younger age, male sex, being unmarried, and marginal housing were associated with use (p